Score Overview
Explore the 2021 public Archive ranking โ
Where AngioDynamics Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ANGO
2015: 52.3% ยท 2021: 96.3% ยท free through 2021 ยท longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-11-17 | $ 11.49 | โ |
1 Year2025-11-17 | $ 11.91 | -3.53% |
5 Years2021-11-17 | $ 29.51 | -61.06% |
10 Years2016-11-17 | $ 16.78 | -31.53% |
20 Years2006-11-17 | $ 21.28 | -46.01% |
All Time2004-05-27 | $ 12.50 | -8.08% |
| Period | Last Price2026-11-17 | 1 Year2025-11-17 | 5 Years2021-11-17 | 10 Years2016-11-17 | 20 Years2006-11-17 | All Time2004-05-27 |
|---|---|---|---|---|---|---|
| Price | $ 11.49 | $ 11.91 | $ 29.51 | $ 16.78 | $ 21.28 | $ 12.50 |
| Return | โ | -3.53% | -61.06% | -31.53% | -46.01% | -8.08% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 325M | -$ 32M | $ 33M |
| 2026 | $ 320M | -$ 36M | $ 53M |
| 2025 | $ 292M | -$ 33M | $ 55M |
| 2024 | $ 303M | -$ 184M | $ 76M |
| 2023 | $ 338M | -$ 52M | $ 44M |
| 2022 | $ 316M | -$ 26M | $ 28M |
| 2021 | $ 291M | -$ 31M | $ 48M |
| 2020 | $ 264M | -$ 166M | $ 54M |
| 2019 | $ 359M | $ 61M | $ 227M |
| 2018 | $ 344M | $ 16M | $ 75M |
| 2017 | $ 349M | -$ 7M | $ 48M |
| 2016 | $ 353M | -$ 43M | $ 33M |
| 2015 | $ 356M | -$ 3M | $ 20M |
| 2014 | $ 354M | $ 2M | $ 17M |
| 2013 | $ 342M | -$ 1M | $ 23M |
| 2012 | $ 221M | -$ 5M | $ 37M |
| 2011 | $ 215M | $ 8M | $ 131M |
| 2010 | $ 216M | $ 12M | $ 100M |
| 2009 | $ 195M | $ 9M | $ 68M |
| 2008 | $ 166M | $ 10M | $ 78M |
| 2007 | $ 112M | -$ 9M | $ 71M |
| 2006 | $ 78M | $ 6M | $ 89M |
| 2005 | $ 60M | $ 4M | $ 27M |
| IPO2004 | $ 49M | $ 3M | $ 2M |

AngioDynamics Inc fundamental performance
Between 2021 and 2026, revenue grew from $ 291M to $ 320M and net income went from -$ 31M to -$ 36M. Revenue increased in 3 of those 5 years; net income in 2.
Across AngioDynamics Inc's full reported history, from 2004 to 2026, revenue grew from $ 49M to $ 320M and net income went from $ 3M to -$ 36M. Revenue increased in 70% of the years measured; net income in 57%.
AngioDynamics Inc currently holds a 20-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.
Membership
Continue ANGOโs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,187 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio




